Evidence map›Paper›PMID 39982075›Full record

ArticlemSphere2025

A new bacteriophage infecting

Ana Catarina Duarte, Lucía Fernández, Ana Rodríguez, Pilar García

Abstract read
In one paragraph

Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Vancomycin and phage COP-80B combination therapy for Staphylococcus epidermidis periprosthetic joint infections: a preclinical mouse study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. The Evolution of Symbiosis inBiomolecules · 2026
    Review
  3. Isolation and characterization of a novelFrontiers in cellular and infection microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ana Catarina DuarteInstituto de Productos Lácteos de Asturias (IPLA-CSIC), Oviedo, Asturias, Spain.
Lucía FernándezInstituto de Productos Lácteos de Asturias (IPLA-CSIC), Oviedo, Asturias, Spain.ORCID 0000-0002-7383-7595
Ana RodríguezInstituto de Productos Lácteos de Asturias (IPLA-CSIC), Oviedo, Asturias, Spain.ORCID 0000-0002-1577-9905
Pilar GarcíaInstituto de Productos Lácteos de Asturias (IPLA-CSIC), Oviedo, Asturias, Spain.

Funding

EC | H2020 | PRIORITY 'Excellent science' | H2020 Marie Skłodowska-Curie Actions (MSCA) Grant Agreement No. 813439Gobierno del Principado de Asturias (GPA) AYUD/2021/52132MCIN/AEI/10.13039/501100011033/FEDER, UE PID2022-140988OB-I00
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBiofilmsPhage TherapyStaphylococcus epidermidisStaphylococcus PhagesVancomycinGenome, ViralHumansStaphylococcal InfectionsAnti-Bacterial AgentsVancomycinantibioticbacteriophagebiofilmslytic proteinStaphylococcus epidermidissynergy

Identifiers

PMID39982075
PMCPMC11934314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.